Safety profile of robot-assisted radical prostatectomy

A standardized report of complications in 3317 patients

Piyush K. Agarwal, Jesse Sammon, Akshay Bhandari, Ali Dabaja, Mireya Diaz, Stacey Dusik-Fenton, Ramgopal Satyanarayana, Andrea Simone, Quoc Dien Trinh, Brad Baize, Mani Menon

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Background: Previous studies attempting to assess complications after robot-assisted radical prostatectomy (RARP) are limited by their small numbers, short follow-up, or lack of risk factor analysis. Objective: To document complications after RARP by strict application of standardized reporting criteria. Design, setting, and participants: Between January 2005 and December 2009, 3317 consecutive patients underwent RARP at a tertiary referral center. Median follow-up was 24.2 mo (interquartile range: 12.4-36.9). Intervention: Transperitoneal RARP was performed by one of five surgeons - two experienced, three beginners. Measurements: Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, and electronic medical and institutional morbidity and mortality records, and reported according to the Martin-Donat criteria. Complications were stratified by type (medical/surgical), Clavien classification, and timing of onset. Multivariable analysis of factors predictive of complications was performed. Results and limitations: The median hospitalization time was 1 d. There were 368 complications in 326 patients (9.8%), including a transfusion rate of 2.2%. We detected 79 medical complications in 78 patients (2.4%) and 289 surgical complications in 264 patients (8.0%). There were 242 minor (Clavien 1-2) and 126 major (Clavien 3-5) complications. Two hundred ninety-nine (81.3%) complications occurred within 30 d, 17 (4.6%) within 31-90 d, and 52 (14.1%) after 90 d from surgery. On multivariable analysis, preoperative prostate-specific antigen values and cardiac comorbidity were predictive for medical complications, whereas age, gastroesophageal reflux disease, and biopsy Gleason score were predictive of surgical complications. Limitations of this study include representing results from a single high-volume referral center and not including the learning curve of the two most experienced surgeons. Conclusions: RARP is a safe operation, with an overall complication rate of 9.8%. Most complications occurred within 30 d of surgery.

Original languageEnglish
Pages (from-to)684-698
Number of pages15
JournalEuropean Urology
Volume59
Issue number5
DOIs
StatePublished - May 1 2011
Externally publishedYes

Fingerprint

Prostatectomy
Safety
Statistical Factor Analysis
Medical Electronics
Learning Curve
Neoplasm Grading
Prostate-Specific Antigen
Gastroesophageal Reflux
Tertiary Care Centers
Comorbidity
Prostatic Neoplasms
Hospitalization
Referral and Consultation
Databases
Morbidity
Biopsy
Mortality
Surgeons

Keywords

  • Complications
  • Prostatectomy
  • RARP
  • Robotic

ASJC Scopus subject areas

  • Urology

Cite this

Agarwal, P. K., Sammon, J., Bhandari, A., Dabaja, A., Diaz, M., Dusik-Fenton, S., ... Menon, M. (2011). Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients. European Urology, 59(5), 684-698. https://doi.org/10.1016/j.eururo.2011.01.045

Safety profile of robot-assisted radical prostatectomy : A standardized report of complications in 3317 patients. / Agarwal, Piyush K.; Sammon, Jesse; Bhandari, Akshay; Dabaja, Ali; Diaz, Mireya; Dusik-Fenton, Stacey; Satyanarayana, Ramgopal; Simone, Andrea; Trinh, Quoc Dien; Baize, Brad; Menon, Mani.

In: European Urology, Vol. 59, No. 5, 01.05.2011, p. 684-698.

Research output: Contribution to journalArticle

Agarwal, PK, Sammon, J, Bhandari, A, Dabaja, A, Diaz, M, Dusik-Fenton, S, Satyanarayana, R, Simone, A, Trinh, QD, Baize, B & Menon, M 2011, 'Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients', European Urology, vol. 59, no. 5, pp. 684-698. https://doi.org/10.1016/j.eururo.2011.01.045
Agarwal, Piyush K. ; Sammon, Jesse ; Bhandari, Akshay ; Dabaja, Ali ; Diaz, Mireya ; Dusik-Fenton, Stacey ; Satyanarayana, Ramgopal ; Simone, Andrea ; Trinh, Quoc Dien ; Baize, Brad ; Menon, Mani. / Safety profile of robot-assisted radical prostatectomy : A standardized report of complications in 3317 patients. In: European Urology. 2011 ; Vol. 59, No. 5. pp. 684-698.
@article{b8d5e3bc5ec24cf7b10cdddbe2cae514,
title = "Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients",
abstract = "Background: Previous studies attempting to assess complications after robot-assisted radical prostatectomy (RARP) are limited by their small numbers, short follow-up, or lack of risk factor analysis. Objective: To document complications after RARP by strict application of standardized reporting criteria. Design, setting, and participants: Between January 2005 and December 2009, 3317 consecutive patients underwent RARP at a tertiary referral center. Median follow-up was 24.2 mo (interquartile range: 12.4-36.9). Intervention: Transperitoneal RARP was performed by one of five surgeons - two experienced, three beginners. Measurements: Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, and electronic medical and institutional morbidity and mortality records, and reported according to the Martin-Donat criteria. Complications were stratified by type (medical/surgical), Clavien classification, and timing of onset. Multivariable analysis of factors predictive of complications was performed. Results and limitations: The median hospitalization time was 1 d. There were 368 complications in 326 patients (9.8{\%}), including a transfusion rate of 2.2{\%}. We detected 79 medical complications in 78 patients (2.4{\%}) and 289 surgical complications in 264 patients (8.0{\%}). There were 242 minor (Clavien 1-2) and 126 major (Clavien 3-5) complications. Two hundred ninety-nine (81.3{\%}) complications occurred within 30 d, 17 (4.6{\%}) within 31-90 d, and 52 (14.1{\%}) after 90 d from surgery. On multivariable analysis, preoperative prostate-specific antigen values and cardiac comorbidity were predictive for medical complications, whereas age, gastroesophageal reflux disease, and biopsy Gleason score were predictive of surgical complications. Limitations of this study include representing results from a single high-volume referral center and not including the learning curve of the two most experienced surgeons. Conclusions: RARP is a safe operation, with an overall complication rate of 9.8{\%}. Most complications occurred within 30 d of surgery.",
keywords = "Complications, Prostatectomy, RARP, Robotic",
author = "Agarwal, {Piyush K.} and Jesse Sammon and Akshay Bhandari and Ali Dabaja and Mireya Diaz and Stacey Dusik-Fenton and Ramgopal Satyanarayana and Andrea Simone and Trinh, {Quoc Dien} and Brad Baize and Mani Menon",
year = "2011",
month = "5",
day = "1",
doi = "10.1016/j.eururo.2011.01.045",
language = "English",
volume = "59",
pages = "684--698",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Safety profile of robot-assisted radical prostatectomy

T2 - A standardized report of complications in 3317 patients

AU - Agarwal, Piyush K.

AU - Sammon, Jesse

AU - Bhandari, Akshay

AU - Dabaja, Ali

AU - Diaz, Mireya

AU - Dusik-Fenton, Stacey

AU - Satyanarayana, Ramgopal

AU - Simone, Andrea

AU - Trinh, Quoc Dien

AU - Baize, Brad

AU - Menon, Mani

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Background: Previous studies attempting to assess complications after robot-assisted radical prostatectomy (RARP) are limited by their small numbers, short follow-up, or lack of risk factor analysis. Objective: To document complications after RARP by strict application of standardized reporting criteria. Design, setting, and participants: Between January 2005 and December 2009, 3317 consecutive patients underwent RARP at a tertiary referral center. Median follow-up was 24.2 mo (interquartile range: 12.4-36.9). Intervention: Transperitoneal RARP was performed by one of five surgeons - two experienced, three beginners. Measurements: Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, and electronic medical and institutional morbidity and mortality records, and reported according to the Martin-Donat criteria. Complications were stratified by type (medical/surgical), Clavien classification, and timing of onset. Multivariable analysis of factors predictive of complications was performed. Results and limitations: The median hospitalization time was 1 d. There were 368 complications in 326 patients (9.8%), including a transfusion rate of 2.2%. We detected 79 medical complications in 78 patients (2.4%) and 289 surgical complications in 264 patients (8.0%). There were 242 minor (Clavien 1-2) and 126 major (Clavien 3-5) complications. Two hundred ninety-nine (81.3%) complications occurred within 30 d, 17 (4.6%) within 31-90 d, and 52 (14.1%) after 90 d from surgery. On multivariable analysis, preoperative prostate-specific antigen values and cardiac comorbidity were predictive for medical complications, whereas age, gastroesophageal reflux disease, and biopsy Gleason score were predictive of surgical complications. Limitations of this study include representing results from a single high-volume referral center and not including the learning curve of the two most experienced surgeons. Conclusions: RARP is a safe operation, with an overall complication rate of 9.8%. Most complications occurred within 30 d of surgery.

AB - Background: Previous studies attempting to assess complications after robot-assisted radical prostatectomy (RARP) are limited by their small numbers, short follow-up, or lack of risk factor analysis. Objective: To document complications after RARP by strict application of standardized reporting criteria. Design, setting, and participants: Between January 2005 and December 2009, 3317 consecutive patients underwent RARP at a tertiary referral center. Median follow-up was 24.2 mo (interquartile range: 12.4-36.9). Intervention: Transperitoneal RARP was performed by one of five surgeons - two experienced, three beginners. Measurements: Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, and electronic medical and institutional morbidity and mortality records, and reported according to the Martin-Donat criteria. Complications were stratified by type (medical/surgical), Clavien classification, and timing of onset. Multivariable analysis of factors predictive of complications was performed. Results and limitations: The median hospitalization time was 1 d. There were 368 complications in 326 patients (9.8%), including a transfusion rate of 2.2%. We detected 79 medical complications in 78 patients (2.4%) and 289 surgical complications in 264 patients (8.0%). There were 242 minor (Clavien 1-2) and 126 major (Clavien 3-5) complications. Two hundred ninety-nine (81.3%) complications occurred within 30 d, 17 (4.6%) within 31-90 d, and 52 (14.1%) after 90 d from surgery. On multivariable analysis, preoperative prostate-specific antigen values and cardiac comorbidity were predictive for medical complications, whereas age, gastroesophageal reflux disease, and biopsy Gleason score were predictive of surgical complications. Limitations of this study include representing results from a single high-volume referral center and not including the learning curve of the two most experienced surgeons. Conclusions: RARP is a safe operation, with an overall complication rate of 9.8%. Most complications occurred within 30 d of surgery.

KW - Complications

KW - Prostatectomy

KW - RARP

KW - Robotic

UR - http://www.scopus.com/inward/record.url?scp=79953250400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953250400&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2011.01.045

DO - 10.1016/j.eururo.2011.01.045

M3 - Article

VL - 59

SP - 684

EP - 698

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -